✦ LIBER ✦

Anemia Control in Renal Transplant Recipients Receiving Continuous Erythropoietin Receptor Activator (C.E.R.A.) Treatment: The AnemiaTrans Study

✍ Scribed by Ana I. Sánchez-Fructuoso, Juan C. Ruiz, José V. Torregrosa, Esther González, Ernesto Gómez, Roberto J. Gallego, María I. Troya, Carlos Jimenez, Francisco Llamas, Rafael Romero, Carmen Bernis, José F. Crespo, Luis Guirado

Book ID: 118825503
Publisher: Springer Healthcare Communications
Year: 2012
Tongue: English
Weight: 1003 KB
Volume: 29
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-012-0063-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

59: Efficacy of C.E.R.A., a Continuous E

59: Efficacy of C.E.R.A., a Continuous Erythropoietin Receptor Activator, in Treatment of Renal Anemia: Overview of 6 Global Phase 3 Trials

✍ Steven Fishbane; Cheryl Dalton; Richard Beswick; Paula Dutka; Rebecca Schmidt 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Phase II study of three dose levels of c

Phase II study of three dose levels of continuous erythropoietin receptor activator (C.E.R.A.) in anaemic patients with aggressive non-Hodgkin’s lymphoma receiving combination chemotherapy

✍ Anders Österborg; Juan Luis Steegmann; Andrzej Hellmann; Stephen Couban; Jiri Ma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

The PRIMAVERA study protocol design: Eva

The PRIMAVERA study protocol design: Evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney disease

✍ D. Fliser; F. Dellanna; M. Koch; J. Seufert; O. Witzke; I.A. Hauser 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 343 KB